找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Current Cardiovascular Drugs; William H. Frishman (Professor of Medicine and Pha Book 2000Latest edition Springer Science+Business Media N

[复制链接]
楼主: 压榨机
发表于 2025-3-26 23:54:13 | 显示全部楼层
Eatimad Babikir,Ahmed Abdel Aziz Ahmede effects. As a result, these blockers are now used as third- or fourth-line agents in the management of severe hypertension when the combination of bettertolerated agents has failed to achieve adequate blood pressure (BP) control. . is used for the reduction of BP during surgery and the treatment of hypertensive emergencies.
发表于 2025-3-27 04:47:07 | 显示全部楼层
: Deconstructing the Domestic Ideal,uist suggested the alpha/beta classification scheme to explain differences between the pharmacologic actions of adrenergic agonists. The alpha blockers, . and . (now recognized as antagonists for both alpha. and alpha. receptors), have been in use since the 1960s, primarily for management of massive
发表于 2025-3-27 08:42:04 | 显示全部楼层
https://doi.org/10.1007/978-3-030-30449-2 use has been limited because of the central sedative and depressive effects associated with the antihypertensive action of these drugs. The search continues for similar acting drugs that do not produce these unwanted effects.
发表于 2025-3-27 10:33:20 | 显示全部楼层
Patrick Bosch,Steven Latré,Chris Blondiafailure (CHI). An intravenous agent, ., has been approved by the Food and Drug Administration (FDA) for use in hypertension, and ten oral agents—.—are approved and available in the United States. . has also been approved by the FDA for the treatment of hypertension; however, this agent has not been
发表于 2025-3-27 16:43:58 | 显示全部楼层
发表于 2025-3-27 19:43:26 | 显示全部楼层
Lecture Notes in Computer Scienceinly used to treat supraventricular tachyarrhythmias. Azimilide, with its unique pharmacological profile, may prove to be a beneficial agent in the treatment of ventricular tachyarrhythmias. In addition, the implantable cardioverter defibrillator has become a standard therapy for life-threatening ve
发表于 2025-3-28 01:44:17 | 显示全部楼层
Arkadeep Sen,Krishna M. Sivalingamularly in arteries. Anticoagulant therapy is used to prevent clots from forming or extending by inhibiting the formation of the fibrin framework of the blood clot. Thrombolytic therapy activates the enzyme pathways that lyse the fibrin meshwork of the blood dot to restore blood flow after a dot has
发表于 2025-3-28 03:30:47 | 显示全部楼层
https://doi.org/10.1007/978-3-030-30523-9myocardial contractility are reduced with beta blockade. Beta receptors are also found in a wide range of other tissues. These agents are generally well tolerated, and are widely used for various cardiovascular and other clinical conditions.
发表于 2025-3-28 06:37:00 | 显示全部楼层
发表于 2025-3-28 12:15:30 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-3 21:34
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表